medtex limited

Live MatureMicroLow

medtex limited Company Information

Share MEDTEX LIMITED

Company Number

02279016

Directors

Kevin Holden

Julia Holden

View All

Shareholders

julia marie holden

kevin holden

Group Structure

View All

Industry

Other human health activities

 

Registered Address

unit 9, 139 oldbury road,, smethwick, warley, w.mids, B66 1JE

medtex limited Estimated Valuation

£130.8k

Pomanda estimates the enterprise value of MEDTEX LIMITED at £130.8k based on a Turnover of £307.9k and 0.42x industry multiple (adjusted for size and gross margin).

medtex limited Estimated Valuation

£0

Pomanda estimates the enterprise value of MEDTEX LIMITED at £0 based on an EBITDA of £-7.8k and a 3.13x industry multiple (adjusted for size and gross margin).

medtex limited Estimated Valuation

£212.5k

Pomanda estimates the enterprise value of MEDTEX LIMITED at £212.5k based on Net Assets of £86.5k and 2.46x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

Medtex Limited Overview

Medtex Limited is a live company located in warley, B66 1JE with a Companies House number of 02279016. It operates in the other human health activities sector, SIC Code 86900. Founded in July 1988, it's largest shareholder is julia marie holden with a 50% stake. Medtex Limited is a mature, micro sized company, Pomanda has estimated its turnover at £307.9k with low growth in recent years.

View Sample
View Sample
View Sample

Upgrade for unlimited company reports & a free credit check

Medtex Limited Health Check

Pomanda's financial health check has awarded Medtex Limited a 3 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 6 areas for improvement. Company Health Check FAQs

Health Check Image
Health Rating3out of 5
positive_score

3 Strong

positive_score

1 Regular

positive_score

6 Weak

size

Size

annual sales of £307.9k, make it smaller than the average company (£648.1k)

£307.9k - Medtex Limited

£648.1k - Industry AVG

growth

Growth

3 year (CAGR) sales growth of 4%, show it is growing at a slower rate (6%)

4% - Medtex Limited

6% - Industry AVG

production

Production

with a gross margin of 22.1%, this company has a higher cost of product (39.2%)

22.1% - Medtex Limited

39.2% - Industry AVG

profitability

Profitability

an operating margin of -2.5% make it less profitable than the average company (5.5%)

-2.5% - Medtex Limited

5.5% - Industry AVG

employees

Employees

with 4 employees, this is below the industry average (17)

4 - Medtex Limited

17 - Industry AVG

paystructure

Pay Structure

on an average salary of £26k, the company has an equivalent pay structure (£26k)

£26k - Medtex Limited

£26k - Industry AVG

efficiency

Efficiency

resulting in sales per employee of £77k, this is more efficient (£48.3k)

£77k - Medtex Limited

£48.3k - Industry AVG

debtordays

Debtor Days

it gets paid by customers after 119 days, this is later than average (23 days)

119 days - Medtex Limited

23 days - Industry AVG

creditordays

Creditor Days

its suppliers are paid after 24 days, this is slower than average (19 days)

24 days - Medtex Limited

19 days - Industry AVG

stockdays

Stock Days

There is insufficient data available for this Key Performance Indicator!

- - Medtex Limited

- - Industry AVG

cashbalance

Cash Balance

There is insufficient data available for this Key Performance Indicator!

- - Medtex Limited

- - Industry AVG

debtlevel

Debt Level

it has a ratio of liabilities to total assets of 15.4%, this is a lower level of debt than the average (26.7%)

15.4% - Medtex Limited

26.7% - Industry AVG

MEDTEX LIMITED financials

EXPORTms excel logo

Medtex Limited's latest turnover from October 2023 is estimated at £307.9 thousand and the company has net assets of £86.5 thousand. According to their latest financial statements, Medtex Limited has 4 employees and maintains cash reserves of 0 as reported in the balance sheet.

Data source: Companies HousePomanda Estimates

Oct 2023Oct 2022Oct 2021Oct 2020Oct 2019Oct 2018Oct 2017Oct 2016Oct 2015Oct 2014Oct 2013Oct 2012Oct 2011Oct 2010Oct 2009
Turnover307,858339,927339,275276,666282,489256,480243,318186,280174,427154,796173,262257,541215,429257,8540
Other Income Or Grants000000000000000
Cost Of Sales239,985266,327271,028217,759221,976201,703185,223141,965136,109118,433132,088187,446154,783184,4560
Gross Profit67,87373,60068,24758,90760,51354,77658,09544,31538,31936,36241,17570,09560,64673,3980
Admin Expenses75,71861,20224,19314,44822,43261,36656,03642,68447,66957,81528,47875,838111,62993,402-114,313
Operating Profit-7,84512,39844,05444,45938,081-6,5902,0591,631-9,350-21,45312,697-5,743-50,983-20,004114,313
Interest Payable000000000000000
Interest Receivable000000111419365459161346212
Pre-Tax Profit-7,84512,39844,05444,45938,081-6,5902,0701,645-9,331-21,41712,751-5,684-50,822-19,658114,525
Tax0-2,356-8,370-8,447-7,2350-393-32900-2,933000-32,067
Profit After Tax-7,84510,04235,68436,01230,846-6,5901,6771,316-9,331-21,4179,818-5,684-50,822-19,65882,458
Dividends Paid000000000000000
Retained Profit-7,84510,04235,68436,01230,846-6,5901,6771,316-9,331-21,4179,818-5,684-50,822-19,65882,458
Employee Costs103,876122,029117,491114,783113,161130,420107,76861,42863,84764,73364,40885,18184,50182,1390
Number Of Employees455556533334440
EBITDA*-7,84512,39844,05444,45938,081-6,5902,0591,777-9,194-21,26212,938-5,452-50,664-19,754114,566

* Earnings Before Interest, Tax, Depreciation and Amortisation

Oct 2023Oct 2022Oct 2021Oct 2020Oct 2019Oct 2018Oct 2017Oct 2016Oct 2015Oct 2014Oct 2013Oct 2012Oct 2011Oct 2010Oct 2009
Tangible Assets1,5691,8752,1892,5228857318657096147709611,2021,4461,4791,135
Intangible Assets000000000000000
Investments & Other000000000000000
Debtors (Due After 1 year)000000000000000
Total Fixed Assets1,5691,8752,1892,5228857318657096147709611,2021,4461,4791,135
Stock & work in progress00000009569021,2319331,491930561814
Trade Debtors100,720114,306107,15272,40666,30447,23951,62124,78823,27120,18726,82535,61132,91845,20640,067
Group Debtors000000000000000
Misc Debtors000000000000000
Cash00000008,8092,4215,1649,17212,42310,99053,48384,890
misc current assets000000000000000
total current assets100,720114,306107,15272,40666,30447,23951,62134,55326,59426,58236,93049,52544,83899,250125,771
total assets102,289116,181109,34174,92867,18947,97052,48635,26227,20827,35237,89150,72746,284100,729126,906
Bank overdraft000000000000000
Bank loan000000000000000
Trade Creditors 15,78321,83025,03226,30354,57666,20364,12947,58240,84431,65720,58743,19333,01736,61843,402
Group/Directors Accounts000000000000000
other short term finances000000000000000
hp & lease commitments000000000000000
other current liabilities000000000000000
total current liabilities15,78321,83025,03226,30354,57666,20364,12947,58240,84431,65720,58743,19333,01736,61843,402
loans000000000000000
hp & lease commitments000000000000000
Accruals and Deferred Income000000000000000
other liabilities000000000000000
provisions000000000019224028931146
total long term liabilities000000000019224028931146
total liabilities15,78321,83025,03226,30354,57666,20364,12947,58240,84431,65720,77943,43333,30636,92943,448
net assets86,50694,35184,30948,62512,613-18,233-11,643-12,320-13,636-4,30517,1127,29412,97863,80083,458
total shareholders funds86,50694,35184,30948,62512,613-18,233-11,643-12,320-13,636-4,30517,1127,29412,97863,80083,458
Oct 2023Oct 2022Oct 2021Oct 2020Oct 2019Oct 2018Oct 2017Oct 2016Oct 2015Oct 2014Oct 2013Oct 2012Oct 2011Oct 2010Oct 2009
Operating Activities
Operating Profit-7,84512,39844,05444,45938,081-6,5902,0591,631-9,350-21,45312,697-5,743-50,983-20,004114,313
Depreciation0000000146156191241291319250253
Amortisation000000000000000
Tax0-2,356-8,370-8,447-7,2350-393-32900-2,933000-32,067
Stock000000-95654-329298-558561369-253814
Debtors-13,5867,15434,7466,10219,065-4,38226,8331,5173,084-6,638-8,7862,693-12,2885,13940,067
Creditors-6,047-3,202-1,271-28,273-11,6272,07416,5476,7389,18711,070-22,60610,176-3,601-6,78443,402
Accruals and Deferred Income000000000000000
Deferred Taxes & Provisions000000000-192-48-49-2226546
Cash flow from operations-306-314-3331,637154-134-7,6646,615-2,762-4,044-3,3051,421-42,368-31,15985,066
Investing Activities
capital expenditure306314333-1,637-154134-156-241000-47-286-594-1,388
Change in Investments000000000000000
cash flow from investments306314333-1,637-154134-156-241000-47-286-594-1,388
Financing Activities
Bank loans000000000000000
Group/Directors Accounts000000000000000
Other Short Term Loans 000000000000000
Long term loans000000000000000
Hire Purchase and Lease Commitments000000000000000
other long term liabilities000000000000000
share issue000000-1,00000000001,000
interest000000111419365459161346212
cash flow from financing000000-98914193654591613461,212
cash and cash equivalents
cash000000-8,8096,388-2,743-4,008-3,2511,433-42,493-31,40784,890
overdraft000000000000000
change in cash000000-8,8096,388-2,743-4,008-3,2511,433-42,493-31,40784,890

medtex limited Credit Report and Business Information

Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for medtex limited. Get real-time insights into medtex limited's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Medtex Limited Competitor Analysis

competitor_analysis_table_img

Perform a competitor analysis for medtex limited by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other micro companies, companies in B66 area or any other competitors across 12 key performance metrics.

medtex limited Ownership

MEDTEX LIMITED group structure

Medtex Limited has no subsidiary companies.

Ultimate parent company

MEDTEX LIMITED

02279016

MEDTEX LIMITED Shareholders

julia marie holden 50%
kevin holden 50%

medtex limited directors

Medtex Limited currently has 3 directors. The longest serving directors include Mr Kevin Holden (Jan 1992) and Mrs Julia Holden (Feb 2010).

officercountryagestartendrole
Mr Kevin Holden67 years Jan 1992- Director
Mrs Julia HoldenUnited Kingdom64 years Feb 2010- Director
Mr Robert HoldenUnited Kingdom38 years Feb 2012- Director

P&L

October 2023

turnover

307.9k

-9%

operating profit

-7.8k

0%

gross margin

22.1%

+1.83%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

October 2023

net assets

86.5k

-0.08%

total assets

102.3k

-0.12%

cash

0

0%

net assets

Total assets minus all liabilities

medtex limited company details

company number

02279016

Type

Private limited with Share Capital

industry

86900 - Other human health activities

incorporation date

July 1988

age

37

incorporated

UK

ultimate parent company

None

accounts

Micro-Entity Accounts

last accounts submitted

October 2023

previous names

N/A

accountant

NICKLIN ACCOUNTANCY SERVICES LIMITED

auditor

-

address

unit 9, 139 oldbury road,, smethwick, warley, w.mids, B66 1JE

Bank

-

Legal Advisor

-

medtex limited Charges & Mortgages

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We did not find charges/mortgages relating to medtex limited.

medtex limited Capital Raised & Share Issues BETA

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for MEDTEX LIMITED. This can take several minutes, an email will notify you when this has completed.

medtex limited Companies House Filings - See Documents

datedescriptionview/download